New Issue: Oxigene raises $23.7 million in upsized follow-on at $3.65, discounted from $4.30 close

By Ronda Fears

Nashville, Dec. 15 - Oxigene, Inc. priced an upsized follow-on offering of 6.5 million shares of common stock at $3.65 per share, discounted from Wednesday's closing level of $4.30, via bookrunner SG Cowen & Co. LLC.

The off-the-shelf deal for $23.725 million in proceeds was boosted from 6 million shares.

Waltham, Mass.-based Oxigene is engaged in research and development of products to treat cancer and certain eye diseases.

Issuer:	Oxigene Inc.
Issue:	Follow-on stock offering
Proceeds:	$23.725 million
Shares:	6.5 million shares, up from 6 million
Greenshoe:	900,000 shares
Price:	$3.65 per share
Bookrunner:	SG Cowen & Co. LLC
Co-manager:	Lazard Capital Markets LLC
Pricing date:	Dec. 15
Settlement date:	Dec. 20
Ticker:	OXGN
Stock price:	$4.30 at close Dec. 14

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.